Clinical Trials: What You Need to Know

+ -Text Size

TOPICS

Previous Topic

To learn more

References

American Society of Clinical Oncology. Summary the Affordable Care Act Statute Regarding Insurance Coverage for Individuals Participating in Approved Clinical Trials. Accessed at www.asco.org/sites/default/files/aca_summary_clinical_trials.pdf on September 25, 2014.

Bennett C, Adams J, Knox K, et al. Clinical trials: Are they a good buy? J Clin Oncol. 2001;19:4330-4339.

Center for Information and Study on Clinical Research Participation. 2013 Perceptions & Insights Study. Report on Study Participant Experiences. Accessed at www.ciscrp.org/wp-content/uploads/2014/01/2013-CISCRP-Study-Study-Participant-Experiences.pdf on September 16, 2014.

Centers for Medicare & Medicaid Services. Clinical research studies. Accessed at www.medicare.gov/coverage/clinical-research-studies.html on September 17, 2014.

Coalition of Cancer Cooperative Groups. Most cancer patients satisfied with clinical trial experience, yet, few aware of opportunity: study shows improved physician-patient communications could increase enrollment in cancer clinical trials [press release]. June 5, 2006. Accessed at www.cancertrialshelp.org/CTHpdf/CancerPatientsSatisfied5June06.pdf on September 23, 2014.

Coloma PM. Phase 0 clinical trials: theoretical and practical implications in oncologic drug development. Open Access Journal of Clinical Trials. 2013;5:119-126.

Dilts DM, Sandler A, Cheng S, et al. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. J Clin Oncol. 2009;27(11):1761-1766.

Doroshaw JH. Phase ‘0’ Clinical Trials in Cancer Drug Development: From Concept to Practice. Slide presentation. Accessed at www.iom.edu/~/media/Files/Activity%20Files/Disease/NCPF/Phase0ClinicalTrialsinCancerDrugDevelopmentFromConcepttoPracticeDoroshow.pdf on September 23, 2014.

ECRI: Should I Enter a Clinical Trial? A Patient Reference Guide for Adults with a Serious or Life-Threatening Illness. ECRI; February 2002. Accessed at www.ecri.org/Documents/Clinical_Trials_Patient_Reference_Guide.pdf on September 23, 2014.

Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials, 4th ed. 2010. New York, NY: Springer Science + Business Media, LLC.

Getz K, Borfitz D. Informed Consent: The Consumer’s Guide to the Risks and Benefits of Volunteering for Clinical Trials. Boston, Mass: CenterWatch; 2002.

Medscape Oncology. Marshall JL. Why Are Only 3% of US Cancer Patients in Clinical Trials? 01/17/2013. Accessed at www.medscape.com/viewarticle/777662 on September 16, 2014.

National Cancer Institute. Children’s Assent to Clinical Trial Participation. Accessed at www.cancer.gov/clinicaltrials/learningabout/patientsafety/childrensassent on September 24, 2014.

National Cancer Institute. Learning About Clinical Trials. Accessed at www.cancer.gov/clinicaltrials on September 21, 2014.

National Cancer Institute. Patient Safety in Clinical Trials. Accessed at www.cancer.gov/clinicaltrials/learningabout/patientsafety on September 23, 2014.

National Cancer Institute. New Approaches to Cancer Drug Development and Clinical Trials: Questions and Answers. (2007) Accessed at www.cancer.gov/newscenter/pressreleases/PhaseZeroNExTQandA/print?page=&keyword= on September 23, 2014.

Pharmaceutical Research and Manufacturers of America (PhRMA). 2012 Report: Medicines in Development, Cancer. Accessed at www.phrma.org/sites/default/files/1000/phrmamedicinesindevelopmentcancer2012.pdf on September 20, 2012.

Streiner DL, Norman GR. Drug Trial Phases. Community Oncology. 2009;6(1):36-40.

Stryker JE, Wray RJ, Emmons KM, Winer E, Demetri G. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Educ Couns. 2006;63(1-2):104-109.

Tufts Center for the Study of Drug Development 2001: Backgrounder: How new drugs move through the development and approval process. Accessed at http://csdd.tufts.edu/files/uploads/how_new_drugs_move.pdf on September 16, 2014.

US Department of Health and Human Services. Medicare & Clinical Research Studies. September 2012. Accessed at www.medicare.gov/Publications/Pubs/pdf/02226.pdf on September 23, 2014.

US Department of Health, Education, and Welfare. The Belmont Report: Ethical Principles and Guidelines for the protection of human subjects of research, 1979. Accessed at www.hhs.gov/ohrp/humansubjects/guidance/belmont.html on September 23, 2014.

US Food and Drug Administration. Investigational New Drug Application. Accessed at www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm on September 20, 2012.

US Food and Drug Administration. New Drug Development Timeline. Accessed at www.fda.gov/fdac/graphics/newdrugspecial/drugchart.pdf on April 29, 2008. Content no longer available.


Last Medical Review: 09/25/2014
Last Revised: 10/31/2014